SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Vincent van Gogh Synthetic CCD

PatientVincent van Gogh
Date of birth1990-03-30
IdentifiersMRN HR-NI010-SYN; SSN (made up) 000-10-3198
Document date2026-11-01
AuthorElise Verhoeven, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis, antipsychotic monitoring baseline, first-episode workup, alcohol, sleep, and safety planning. Concerns: He wants to understand what happened to him and to stop it happening again, and is frightened that it will; He wants to paint every day again and to be able to concentrate; He is worried about his drinking and his sleep. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aripiprazole 10 mg oral tablet, one tablet by mouth once daily (started in hospital)One tablet by mouth once dailyOral route2026-01-05 to 2026-02-02completedS
Aripiprazole 15 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route2026-02-02 to 2026-02-16completedS
Naltrexone 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route2026-02-02activeS
Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet by mouth dailyOral route2026-01-05 to 2026-07-20completedS
Aripiprazole 10 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route2026-02-16activeS
Propranolol 10 mg oral tablet, one tablet by mouth twice daily for akathisiaOne tablet by mouth twice dailyOral route2026-02-16 to 2026-03-02completedS

Procedures

ProcedureDatesStatusEvidence
Brain MRI without contrast2026-02-02 to 2026-02-02completedS
Sleep-deprived routine EEG2026-02-02 to 2026-02-02completedS
Advance care planning conversation with a psychiatric advance directive, about 20 minutes2026-06-15 to 2026-06-15completedS

Immunizations

DateVaccineStatusEvidence
2026-06-15Pneumococcal conjugate vaccine PCV20completedS
2026-06-15Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
2026-07-20Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1886Heavy drinking, probably both absinthe and wine, from his time in ParisD (CLM-0009)
December 23, 1888First crisis, with confusion and an injury to his left ear; hospital care in Arles with several days in isolation; went home after about two weeksD (CLM-0003, CLM-0004)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He wants to understand what happened to him and to stop it happening again, and is frightened that it willactiveS
He wants to paint every day again and to be able to concentrateactiveS
He is worried about his drinking and his sleepactiveS

Assessment

Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.4 on 2026-07-20; Hemoglobin [Mass/volume] in Blood 14.6 on 2026-07-20; MCV [Entitic mean volume] in Red Blood Cells by Automated count 95 on 2026-07-20; Platelets [#/volume] in Blood by Automated count 214 on 2026-07-20; Sodium [Moles/volume] in Serum or Plasma 137 on 2026-01-19; Potassium [Moles/volume] in Serum or Plasma 4.1 on 2026-01-19; Creatinine [Mass/volume] in Serum or Plasma 0.94 on 2026-01-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 108 on 2026-01-19; Fasting glucose [Mass/volume] in Serum or Plasma 94 on 2026-04-20; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 2026-04-20; Cholesterol [Mass/volume] in Serum or Plasma 191 on 2026-04-20; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 2026-04-20; Cholesterol in HDL [Mass/volume] in Serum or Plasma 50 on 2026-04-20; Triglyceride [Mass/volume] in Serum or Plasma 142 on 2026-04-20; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 on 2026-07-20; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 on 2026-07-20; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 36 on 2026-07-20; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 2026-01-19; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 388 on 2026-01-19; Phosphatidylethanol [Mass/volume] in Blood 16 on 2026-07-20; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-06-15; Total score [AUDIT-C] 3 on 2026-06-15 [S]

Strengths and supports: Supports: a friend he paints with who lives nearby, and the coordinated specialty care team; his work is his strongest reason to get well. He decides who is told about his health [S]

Problems

ProblemClinical statusVerificationCodeProvenance
First episode of psychosis with mood features: weeks of very little sleep, intense work and expansive plans, then acute confusion, hallucinations and suspiciousness with self-injury, and low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal delirium or alcohol-induced psychotic disorder, and psychosis related to focal epilepsy. Synthetic modern episode linked to his documented first crisisactiveprovisional F29S — Synthetic modern coding of the documented first crisis. Unspecified psychosis is coded because the cause is not yet established; the retrospective diagnoses stay in the claims.
Alcohol use disorder, moderate (heavy daily wine and anise spirits before the episode); synthetic modern episode linked to his documented heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding of the documented drinking and its retrospective interpretation.
Self-injury to the left ear during the acute confusional episode, without suicidal intent; wound healed after surgical care in hospitalactiveconfirmed Z91.52S — Synthetic modern coding of the documented injury; no detail of the injury is recorded.
Akathisia from aripiprazole, two weeks after the dose was increased to 15 mg; treated by returning to 10 mg and short-term propranolol; resolvedresolvedconfirmed G25.71S — Synthetic medication side effect; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-19Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-01-19Hemoglobin [Mass/volume] in Blood14.2g/dL13.2-16.6 g/dLNormalS
2026-01-19MCV [Entitic mean volume] in Red Blood Cells by Automated count102fL80-100 fLHighS
2026-01-19Platelets [#/volume] in Blood by Automated count17210*3/uL150-400 10*3/uLNormalS
2026-01-19Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-01-19Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-01-19Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.74-1.35 mg/dLNormalS
2026-01-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M108mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-01-19Fasting glucose [Mass/volume] in Serum or Plasma91mg/dL70-99 mg/dLNormalS
2026-01-19Hemoglobin A1c/Hemoglobin.total in Blood5.3%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
2026-01-19Cholesterol [Mass/volume] in Serum or Plasma184mg/dL<=199 mg/dLNormalS
2026-01-19Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation106mg/dL<=129 mg/dLNormalS
2026-01-19Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
2026-01-19Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
2026-01-19Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma58U/L10-40 U/LHighS
2026-01-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma44U/L7-56 U/LNormalS
2026-01-19Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma96U/L8-61 U/LHighS
2026-01-19Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
2026-01-19Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma388pg/mL232-1245 pg/mLNormalS
2026-01-19Phosphatidylethanol [Mass/volume] in Blood284ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
2026-01-19Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]13{score}S
2026-01-19Total score [AUDIT-C]9{score}S
2026-02-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]11{score}S
2026-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma41U/L10-40 U/LHighS
2026-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma37U/L7-56 U/LNormalS
2026-03-02Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma68U/L8-61 U/LHighS
2026-03-02Phosphatidylethanol [Mass/volume] in Blood122ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
2026-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-04-20Fasting glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-04-20Hemoglobin A1c/Hemoglobin.total in Blood5.4%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
2026-04-20Cholesterol [Mass/volume] in Serum or Plasma191mg/dL<=199 mg/dLNormalS
2026-04-20Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-04-20Cholesterol in HDL [Mass/volume] in Serum or Plasma50mg/dL>=40 mg/dLNormalS
2026-04-20Triglyceride [Mass/volume] in Serum or Plasma142mg/dL<=149 mg/dLNormalS
2026-04-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma33U/L10-40 U/LNormalS
2026-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-56 U/LNormalS
2026-04-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma49U/L8-61 U/LNormalS
2026-04-20Phosphatidylethanol [Mass/volume] in Blood46ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
2026-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-07-20Leukocytes [#/volume] in Blood by Automated count6.410*3/uL4-11 10*3/uLNormalS
2026-07-20Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
2026-07-20MCV [Entitic mean volume] in Red Blood Cells by Automated count95fL80-100 fLNormalS
2026-07-20Platelets [#/volume] in Blood by Automated count21410*3/uL150-400 10*3/uLNormalS
2026-07-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L10-40 U/LNormalS
2026-07-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L7-56 U/LNormalS
2026-07-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma36U/L8-61 U/LNormalS
2026-07-20Phosphatidylethanol [Mass/volume] in Blood16ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingNormalS
2026-07-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-06-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-06-15Total score [AUDIT-C]3{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-01-19Body height170cmS
2026-01-19Body weight64kgS
2026-01-19Body mass index (BMI) [Ratio]22.1kg/m2S
2026-01-19Systolic blood pressure128mm[Hg]S
2026-01-19Diastolic blood pressure80mm[Hg]S
2026-01-19Heart rate88/minS
2026-01-19Respiratory rate16/minS
2026-01-19Body temperature36.7CelS
2026-01-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-02-02Body height170cmS
2026-02-02Body weight64.5kgS
2026-02-02Body mass index (BMI) [Ratio]22.3kg/m2S
2026-02-02Systolic blood pressure124mm[Hg]S
2026-02-02Diastolic blood pressure78mm[Hg]S
2026-02-02Heart rate82/minS
2026-02-02Respiratory rate14/minS
2026-02-02Body temperature36.6CelS
2026-02-02Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-03-02Body height170cmS
2026-03-02Body weight64.9kgS
2026-03-02Body mass index (BMI) [Ratio]22.5kg/m2S
2026-03-02Systolic blood pressure120mm[Hg]S
2026-03-02Diastolic blood pressure76mm[Hg]S
2026-03-02Heart rate76/minS
2026-03-02Respiratory rate14/minS
2026-03-02Body temperature36.6CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-20Body height170cmS
2026-04-20Body weight65.7kgS
2026-04-20Body mass index (BMI) [Ratio]22.7kg/m2S
2026-04-20Systolic blood pressure122mm[Hg]S
2026-04-20Diastolic blood pressure78mm[Hg]S
2026-04-20Heart rate74/minS
2026-04-20Respiratory rate14/minS
2026-04-20Body temperature36.7CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-07-20Body height170cmS
2026-07-20Body weight65.4kgS
2026-07-20Body mass index (BMI) [Ratio]22.6kg/m2S
2026-07-20Systolic blood pressure118mm[Hg]S
2026-07-20Diastolic blood pressure76mm[Hg]S
2026-07-20Heart rate70/minS
2026-07-20Respiratory rate14/minS
2026-07-20Body temperature36.6CelS
2026-07-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-02-16Body height170cmS
2026-02-16Body weight64.4kgS
2026-02-16Body mass index (BMI) [Ratio]22.3kg/m2S
2026-02-16Systolic blood pressure130mm[Hg]S
2026-02-16Diastolic blood pressure82mm[Hg]S
2026-02-16Heart rate96/minS
2026-02-16Respiratory rate16/minS
2026-02-16Body temperature36.7CelS
2026-02-16Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-15Body height170cmS
2026-06-15Body weight65.8kgS
2026-06-15Body mass index (BMI) [Ratio]22.8kg/m2S
2026-06-15Systolic blood pressure120mm[Hg]S
2026-06-15Diastolic blood pressure78mm[Hg]S
2026-06-15Heart rate70/minS
2026-06-15Respiratory rate14/minS
2026-06-15Body temperature36.6CelS
2026-06-15Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-01-19Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis, antipsychotic monitoring baseline, first-episode workup, alcohol, sleep, and safety planningfinishedS
2026-02-02Two-week review and psychiatry consultation with the coordinated specialty care teamfinishedS
2026-03-02Six-week review: symptoms, side effects, alcohol, sleep, and test resultsfinishedS
2026-04-20Three-month review with the 12-week metabolic checkfinishedS
2026-07-20Six-month review: diagnosis, relapse prevention, movement check, and alcoholfinishedS
2026-02-16Same-day sick visit for restlessness after an antipsychotic dose increasefinishedS
2026-06-15Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Continue the antipsychotic started in hospital at the lowest effective dose, with side-effect checks at each visit (akathisia, stiffness, sedation) and monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose, A1c and lipids at baseline, 12 weeks and yearly, and the AIMS at baseline and every six monthscompletedGL-APA-SCZ-2020, GL-ADA-APA-2004, GL-CMID-2026S
Psychiatry consultation with the first-episode psychosis coordinated specialty care team to review the provisional diagnosis and differential, the dose, the alcohol plan, and the workup for epilepsycompletedGL-APA-SCZ-2020, GL-NIMH-CSCS
First-episode workup: blood count, metabolic panel, liver tests, thyroid test, vitamin B12, HIV and syphilis tests, urine drug test, brain MRI, and a sleep-deprived EEG because of the confusion and the question of seizurescompletedGL-APA-SCZ-2020S
Alcohol care: AUDIT-C, PEth at each check to follow drinking, brief counseling with goals he chooses, thiamine, and a medicine for alcohol use disorder once the liver tests are reviewedcompletedGL-SUD-2021, GL-USPSTF-ALC-2018, GL-APA-SCZ-2020S
Coordinated specialty care: a care coordinator, individual resilience-focused therapy, education about psychosis for him and for the people he chooses, support to return to painting and selling his work, and a peer specialistcompletedGL-NIMH-CSC, GL-APA-SCZ-2020S
Sleep as treatment and as an early warning sign: regular sleep and wake times, no alcohol to get to sleep, less coffee after noon, and a plan to call the team after two nights of short sleepcompletedGL-CANMAT-BD-2018, GL-APA-SCZ-2020S
Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, PHQ-9 at each visit, and safety review at every visitcompletedGL-SUICIDE-2024, GL-CMID-2026, GL-USPSTF-DEP-2023S
Akathisia: aripiprazole back to 10 mg daily, propranolol 10 mg twice daily for a few weeks, and a check of restlessness and of safety at each visit until it settlescompletedGL-APA-SCZ-2020S

Goals

GoalTargetStatusOutcomeProvenance
No return of psychotic symptoms and no readmission through six months, on the lowest effective antipsychotic dose2026-07-20completedNo psychotic symptoms since the six-week visit and no admission; aripiprazole 10 mg dailyS
PHQ-9 score below 5 by six months2026-07-20completedPHQ-9 3S
Reduce drinking to PEth below 20 ng/mL by six months2026-07-20completedPEth 16 ng/mL from 284S
Weight gain under 5% and normal glucose, A1c and lipids at the 12-week check2026-04-20completedWeight 65.7 kg from 64.0 (2.7%); fasting glucose 94 mg/dL, A1c 5.4%, lipids normalS
Sleep about seven hours on most nights with regular times by three months2026-04-20completedSeven hours on most nights, in bed by midnightS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-01-19: current ideation present, intent absent, plan absent. Outpatient care with close follow-up. He has passive thoughts that it would be easier not to wake up, without intent, plan or preparation; the self-injury during the episode happened in confusion and without suicidal intent. His risk is higher in the months after a first episode of psychosis, while he is depressed, and while he is drinking. A written safety plan was made with him, with his own early warning signs (nights with little sleep, hearing voices, drinking more, pulling away from his friend) and what to do about each. Lethal-means counseling: he has no firearm and no access to one and agreed not to acquire one; medicines are dispensed two weeks at a time; he will keep alcohol out of the house while he is low. The 988 Suicide & Crisis Lifeline was given and saved in his phone, with the clinic number. Safety reviewed at every visit [S]